Universal HealthcareBy NextBestFit

Price limits can cause shortages, launch delays, or exits

If a single buyer sets prices too low, manufacturers may not launch products, generic makers may stop producing, and providers may leave or limit services.

Evidence

Who's affected

Who is hurt
Who gains while it lasts

Under your mix of paths

Paths that create or worsen it
Paths that fix or soften it
Using your saved plan. 0 paths picked.Edit all picks
Root causes
  • Prices below what sustains supply

Open questions

  • How should prices be set to sustain supply and innovation?

Caused or worsened by these paths

This problem only matters if one of these paths is chosen.

Cap commercial prices at a multiple of MedicareU.S. prices are far higher than in other countriesChosen

Capping commercial payments reduces revenue for hospitals dependent on high commercial prices.

National negotiation for all drugsBrand-name drug prices far above production costChosen

National price negotiation may lead manufacturers to delay drug launches.

International reference pricingBrand-name drug prices far above production costRejected

Linking domestic price caps to foreign prices may lead manufacturers to raise prices abroad or delay launches there.

Solution paths (3)

Open a path for what it fixes, what it creates or worsens, who gains and who loses, precedents, and how it connects to other paths. See all paths as a decision tree.

Set minimum prices or multi-year contracts for essential generics and services so supply stays profitable.

  • +Price limits can cause shortages, launch delays, or exits
  • +Drug shortages of cheap, essential generics
  • −Raises spending or loosens control over it
  • −Depends on uncertain evidence or judgments

Track launches, discontinuations, and provider participation; raise prices automatically when supply falls.

  • +Price limits can cause shortages, launch delays, or exits
  • −Solves only part of the problem
  • −Requires new or changing information systems

Link favorable pricing to launching in the U.S. promptly.

  • +Price limits can cause shortages, launch delays, or exits
  • +Slower access to new drugs and technology
  • −Requires difficult enforcement
  • −Faces political, industry, or legal opposition